2026-09-20T06:26:26Zhttps://wakespace.lib.wfu.edu/server/oai/request

oai:null:10339/147082026-09-02T14:34:02Zcom_10339_14934col_10339_38132

Allen, Stewart 2009-06-04T18:53:50Z 2010-06-18T18:57:43Z 2009-06-04T18:53:50Z 2010-06-18T18:57:43Z 2009-06-04T18:53:50Z https://wakespace.lib.wfu.edu/handle/10339/14708 Cyclooxygenase-2 (COX-2) inhibitors and non-selective nonsteroidal anti-inflammatory medications (NSAIDs) have been associated with increased cardiovascular risk. It is the intent of this discussion to explore mechanisms by which celecoxib, rofecoxib, and nonselective anti-inflammatory medications influence cardiovascular risk. Specifically, I will present data from the Multi-Ethnic Study of Atherosclerosis in order to identify an association of nonsteroidal anti-inflammatory medications with indices of thrombosis and endothelial function. It is my hope that this discussion will lead to a more complete understanding of the cardiovascular risk associated with this class of medications that has had a dramatic effect on public health. en_US Wake Forest University COX-2 inhibitors NSAID thrombosis endothelial function The Association of Celecoxib, Rofecoxib, and Non-selective NSAIDs with Indices of Thrombosis and Endothelial Function in the Multi-Ethnic Study of Atherosclerosis Thesis Release the entire work immediately for access worldwide. Furberg, Curt Chen, Haiying Herrington, David Sane, David Clinical Epidemiology & Health Services open.access